“…Level of Evidence: V d Treatment regimens that limit, or even reduce, the incidence of bacterial antibiotic resistance are recommended o Selection pressure can affect other, more pathogenic bacteria in addition to P acnes 53,54 o High rates of resistance have been correlated with high outpatient use of antibiotics 55 d Use of oral antibiotics can lead to resistance in commensal flora at all body sites; topical antibiotics lead to resistance largely confined to skin of treated site 56 o Oral antibiotics are recommended for moderate to moderately severe acne 1 o Topical antibiotics may be used in mild to moderate acne as long as they are combined with benzoyl peroxide (BPO) and a topical retinoid 1 o Limit the duration of antibiotic use 1,57 and assess response to antibiotics and continuing need at 6 to 12 weeks o Some countries have regulatory guidance limiting the duration of use of topical antibiotics (alone and in fixeddose combination products) to 11 to 12 weeks d Use BPO concomitantly as a leave-on or as a wash o BPO for 5 to 7 days between antibiotic courses may reduce resistant organisms on the skin; however, BPO does not fully eradicate potential for resistant organisms d Avoid using antibiotics (either oral or topical) as monotherapy either for acute treatment or maintenance therapy d Avoid the simultaneous use of oral and topical antibiotics without BPO, particularly if chemically different J AM ACAD DERMATOL VOLUME 60,NUMBER 5 prescribed for acne on other more pathogenic organisms. To date, neither aspect has been extensively studied; there are some data, as will be discussed below.…”